Associate Professor Brendon Neuen is Program Lead for Renal and Metabolic Health at The George Institute for Global Health and a Staff Specialist Nephrologist and Director of Kidney Trials at Royal North Shore Hospital. He is a Clinical Associate Professor at the University of Sydney and a Conjoint Associate Professor at UNSW Sydney. Dr. Neuen earned his MBBS with First Class Honours and an Academic Medal from James Cook University, an MSc from the University of Oxford, and a PhD from UNSW, and completed postdoctoral training at Brigham and Women’s Hospital, Harvard Medical School.

An internationally recognized expert in cardio-kidney-metabolic health, Dr. Neuen serves as Co-Chair of the SGLT2 Inhibitor Meta-Analysis Cardio-Renal Trialists’ Consortium. His research has informed more than 30 international clinical guidelines, including KDIGO and ADA Standards of Care. He has authored over 150 peer-reviewed publications and serves on multiple editorial boards.